Print this page    •   Back to Web version of article

The Body Covers: The 7th Conference on Retroviruses and Opportunistic Infections

Session 30
State of the Art Lecture: HIV Entry and Its Inhibition
Peter Kim
Howard Hughes Med. Inst., Whitehead Inst. for Biomed. Res., MIT, Cambridge, MA

Coverage provided by Paul Sax, M.D.

January 31, 2000

Click Here to Listen to the Original Lecture


This presentation reviewed the exciting area of HIV entry and fusion as a target for antiviral drug development. For HIV to establish infection, it must first attach to a host cell and fuse with that cell's outer membrane. Two HIV envelope proteins, gp120 and gp41 -- which mediate binding to cellular receptors and fusion respectively -- facilitate the entry of HIV into the cell. An inhibitor of this process, T20, is already in clinical trials and has shown potent antiretroviral activity even when given to patients who have multiply resistant virus. However, drawbacks to this drug (the first of its class) include the need to administer it intravenously as well as the relatively high doses required for it to achieve inhibition of the binding.

In his presentation, Dr. Kim described how his laboratory has characterized the structure of gp41, especially in the crucial step just before HIV-cellular fusion. Using this information, he and his colleagues have identified a "pocket" on the molecule that would be an ideal target for binding and inhibition of gp41 action. They are currently screening various peptides for their ability to bind to this pocket, which eventually he believes will lead to the discovery of orally bioavailable blockers of HIV entry into cells.




This article was provided by TheBodyPRO.com. Copyright Body Health Resources Corporation. All rights reserved.

You can find this article online by typing the following address into your Web browser:
http://www.thebody.com/content/art15251.html

Please Note: Knowledge about HIV changes rapidly. Note the date of this article's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this article.

General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your healthcare provider.